-
Synthetic Biology, Genomics & Advanced Therapeutics23 hours agoNo Nonsense: David Liu Lauds Progress in Disease-Agnostic Gene Editing at ESGCT
Liu ensured that his return visit to ESGCT (having spoken at the congress in Barcelona in 2019) would be one of the highlights of the conference....
-
Synthetic Biology, Genomics & Advanced Therapeutics2 days agoBuilding the Future of AAV Gene Therapy
This eBook brings together perspectives from across the AAV development and manufacturing continuum. It explores how early commercial planning can help avoid costly delays, how standardized...
-
Synthetic Biology, Genomics & Advanced Therapeutics2 days agoHamburg Hosts 2026 European Gene Therapy Conference
GEN's Kevin Davies, PhD, reports from ESGCT where patient safety, expanding access to gene therapy, and progress towards an HIV vaccine were prominent themes among the...
-
AI, Machine Learning & Computational Biology4 days agoSingle-Cell Multiomics: Phenotypic Plasticity in Colorectal Cancer Metastasis
In this GEN webinar, Mirjana Efremova, PhD (Queen Mary University of London) will show how these technologies can be used to analyze primary and liver-metastatic CRC...
-
AI, Machine Learning & Computational Biology5 days agoSpatial Proteomics for Precision Oncology
In this GEN webinar, Bernd Bodenmiller, PhD (University of Zürich), illustrates this integrated approach through two recent examples. The post Spatial Proteomics for Precision Oncology appeared...
-
AI, Machine Learning & Computational Biology1 week agoUsing AI Agents and Bio-Foundation Models to Automate Vector Design for Cell Line Development
In this GEN webinar, Asimov’s VP of Business Development and Commercial Strategy Jamie Freeman, PhD, will show how Asimov combines bio-foundation models, AI agents, and synthetic...
-
AI, Machine Learning & Computational Biology1 week agoBridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling
In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to understand patient tumor states and next-generation preclinical...
-
Drug Discovery & Therapeutics2 weeks agoADC Developmentfrom Concept to Clinic
This eBook brings insight on integrated end-to-end solutions for precision engineered therapeutics. The post ADC Developmentfrom Concept to Clinic appeared first on GEN - Genetic Engineering...
-
Synthetic Biology, Genomics & Advanced Therapeutics2 weeks agoDesigning the Ecosystem for CGT Success
This proceedings eBook, developed in partnership with GEN and Cincinnati Children’s Hospital Applied Gene and Cell Therapy Center, captures perspectives and lessons from The Cell Summit...
-
Synthetic Biology, Genomics & Advanced Therapeutics3 weeks agoMultiomics in 2026 and Beyond
Multiomics analysis combines data from two or more omics layers—such as genomics, transcriptomics, proteomics, and epigenomics. However, published criticisms of multiomics approaches have highlighted concerns about...
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
